XTL BIOPHARMACEUTICALS LTD. Interest Received Classified As Investing Activities
XTL BIOPHARMACEUTICALS LTD. (XTLB) reported Interest Received Classified As Investing Activities of $34.00 thousand for the 12-month period ending 2024-12-31, per its 20-F filed 2025-04-30.
Financial Statements › Cash Flow › Investing Activities
ifrs-full:InterestReceivedClassifiedAsInvestingActivities · last filed 2025-04-30
| Period end | Interest Received Classified As Investing Activities 6 month | Interest Received Classified As Investing Activities 12 month |
|---|---|---|
| 2024-12-31 | $34.00K 20-F · filed 2025-04-30 | |
| 2023-12-31 | $41.00K 20-F · filed 2025-04-30 | |
| 2022-12-31 | $36.00K 20-F · filed 2025-04-30 | |
| 2022-06-30 | $8.00K 6-K · filed 2022-08-24 | |
| 2021-12-31 | $8.00K 20-F · filed 2023-03-22 | |
| 2021-06-30 | $5.00K 6-K · filed 2022-08-24 | |
| 2020-12-31 | $33.00K 20-F · filed 2023-03-22 | |
| 2020-06-30 | $24.00K 6-K · filed 2021-08-24 | |
| 2019-12-31 | $93.00K 20-F · filed 2022-03-30 | |
| 2018-12-31 | $74.00K 20-F/A · filed 2021-05-19 | |
| 2017-12-31 | $4.00K 20-F · filed 2020-03-12 |